Jane Street’s HilleVax HLVX Stock Holding History

Jane Street’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,106	Closed	-$30.1K	–	11181
2025 Q2	$30.1K	Sell	15,106 -41,457	-73%	-$75.8K	﹤0.01%	9290
2025 Q1	$82K	Buy	56,563 +11,991	+27%	+$22.2K	﹤0.01%	8884
2024 Q4	$92.3K	Sell	44,572 -34,467	-44%	-$64.7K	﹤0.01%	8789
2024 Q3	$139K	Buy	79,039 +35,546	+82%	+$91.2K	﹤0.01%	8850
2024 Q2	$629K	Buy	43,493 +11,877	+38%	+$163K	﹤0.01%	6651
2024 Q1	$526K	Buy	31,616 +17,928	+131%	+$287K	﹤0.01%	6586
2023 Q4	$220K	Buy	+13,688	New	+$182K	﹤0.01%	8073

Jane Street's HLVX Position: Q3 2025 in Review

Jane Street sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 15,106 shares — an estimated $30.1K sold.

Jane Street first reported a position in HLVX in Q4 2023 and held it in 7 quarters. The position peaked at $629K in Q2 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

Jane Street reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
Jane Street sold 15,106 HilleVax shares in Q3 2025, an estimated $30.1K.
Jane Street first reported a position in HilleVax in Q4 2023 and held it in 7 quarters.
Jane Street's HilleVax position peaked at $629K in Q2 2024.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.